Metraipolis › archive › dc_3dcf445b9e6e

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast… — Europe PMC PMID:41744870

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41744870
DOI
10.3390/curroncol33020106
License (as archived)
solo-consultazione
Archived
2026-11-06T00:35:03.028Z
SHA-256 of the archived text
bb6188bbec0264add43e993dd8cf40319ccec4f6582038f5a0c85e2506b80b54
Stable URL of this page
https://metraipolis.com/documento/dc_3dcf445b9e6e

How to cite

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast… — Europe PMC PMID:41744870 — Europe PMC (en), https://europepmc.org/article/MED/41744870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3dcf445b9e6e (Metraipolis archive dc_3dcf445b9e6e, sha256 bb6188bbec0264add43e993dd8cf40319ccec4f6582038f5a0c85e2506b80b54)
BibTeX
@misc{dc3dcf445b9e6e,
  title = {Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2- Metastatic Breast… — Europe PMC PMID:41744870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41744870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3dcf445b9e6e; sha256 bb6188bbec0264add43e993dd8cf40319ccec4f6582038f5a0c85e2506b80b54},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744870. Agents can read the archived copy with the MCP tool read_document.